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Purpose: With advances in phenotyping tools and availability of molecular characterization, an increasing number of
phenotypically  and  genotypically  diverse  inherited  corneal  dystrophies  are  described.  We  aimed  to  determine  the
underlying causative genetic mechanism in a three-generation pedigree affected with a unique anterior membrane corneal
dystrophy characterized by early onset recurrent corneal erosions, small discrete focal opacities at the level of Bowman
layer and anterior stroma, anterior stromal flecks, and prominent corneal nerves.
Methods: Twenty affected and unaffected members of a three-generation family were examined and extensively clinically
characterized including corneal topography and in vivo confocal microscopy, and biological specimens were collected
for DNA extraction. Mutational analysis of two corneal genes (TGFBI [Transforming Growth factor-beta induced] and
ZEB1  [zinc finger E box-binding homeobox 1])  was undertaken, in addition to testing with the Asper Corneal Dystrophy
gene chip (Asper Ophthalmics, Tartu, Estonia). Subsequent Genotyping To 11 Known Corneal Gene Loci (COL8A2
[Collagen,  Type  VIII,  Alpha-2],  TACSTD2  [Tumor-Associated  Calcium  Signal  Transducer  2],  PIP5K3
[Phosphatidylinositol-3-Phosphate  5-Kinase,  Type  III],  GSN  [Gelsolin],  KERA  [Keratocan],  VSX1  [Visual  System
Homeobox Gene 1], COL6A1 [Collagen, Type VI, Alpha-1], MMP9 [Matrix Metalloproteinase 9], KRT3 [Keratin 3]),
and  two  putative  loci,  3p14-q13  and  15q22.33–24)  was  undertaken  using  polymorphic  markers,  and  haplotypes
constructed. Multipoint linkage analysis was performed to generate LOD scores and produce LOD plots across the
candidate intervals.
Results:   No  pathogenic  sequence  variations  were  detected  in TGFBI or ZEB1 of the proband  nor  on the Asper 
Corneal Dystrophy gene chip (302 mutations in 12 genes).  Multipoint linkage analysis of 11 known  corneal  genes and loci 
generated negative LOD plots and was able to exclude all genes tested including PIP5K3.
Conclusions: Exclusion of linkage to candidate corneal loci combined with an absence of pathogenic mutations in known
corneal genes in this pedigree suggest a different genetic causative mechanism in this dystrophy than the previously
documented  corneal  genes.  This  unique  phenotype  of  an  anterior  membrane  dystrophy  may  therefore  provide  an
opportunity to identify a new gene responsible for corneal disease.
The inherited corneal dystrophies represent a group of
clinically  and  genetically  heterogeneous  disorders  of  the
cornea, with many genes identified to date. With the advances
in  phenotyping  tools  and  the  availability  of  molecular
characterization,  an  increasing  amount  of  phenotypic  and
genotypic diversity is described in the corneal dystrophies.
The  autosomal  dominantly  inherited  bilateral  corneal
dystrophies  involving  the  anterior  corneal  layers  of  the
epithelial  basement  membrane,  Bowman  layer,  and/or
anterior  stroma  are  typically  described  as  occurring  in
association with TGFBI (Transforming Growth factor-beta
induced) [1] or PIP5K3 (Phosphatidylinositol-3-Phosphate 5-
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Kinase,  Type  III)  [2]  mutations.  The  TGFBI  dystrophies
(granular, lattice, granular dystrophy type 2, and Bowman
layer [Reis-Bückler, Thiel-Behnke])  are well characterized
and  frequently  demonstrate  typical  and  reproducible
phenotype-genotype correlations, yet there are an increasing
number of new phenotypic and genotypic descriptions that are
not compatible with the current forms of corneal dystrophies
[1].
Less  is  published  on  Fleck  corneal  dystrophy  (CFD;
OMIM 121850), a term characteristically used in reference to
the dystrophy initially described by François and Neetens as
“heredodystrophie  Mouchetee  [2],”  which  is  translated  as
“speckled.”  Multiple  flecks  are  predominantly  located
centrally and peripherally in the stroma with clear normal
tissue intervening and no involvement of other layers of the
cornea, including Bowman layer. The disease is usually non-
progressive, and the flecks are typically seen by slit-lamp
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1700biomicroscopy to be predominantly in the posterior corneal
stroma. The majority of patients are asymptomatic. Recurrent
erosions are not a typical feature, although photophobia is
reported  [3,4].  In  vivo  confocal  microscopy  of  fleck
dystrophies highlights small bright deposits in and around
keratocyte nuclei that occur throughout the stroma despite the
clinical appearance [5,6].
Four families with classic Fleck dystrophy demonstrated
linkage to chromosome 2q35 between D2S117 and D2S116
with a maximum multipoint LOD score of 5 halfway between
D2S2289  and  D2S325  [7].  Subsequent  sequencing  of
candidate genes within the interval between D2S2289 and
D2S126 identified pathogenic mutations in PIP5K3 in 8 of 10
families  with  Fleck  dystrophy  [8],  although  incomplete
penetrance  was  documented  in  some  families.  PIP5K3
encodes for a member of the phosphoinositide 3-kinase family
and  is  involved  in  the  regulation  of  endosomal  transport.
However, it must be noted that in addition to being dystrophic,
corneal flecks may also be degenerative, a feature of certain
systemic or topical drugs, or associated with contact lens wear
[5,9].
We  have  identified  a  three-generation  family  with  a
unique corneal dystrophy demonstrating autosomal dominant
inheritance and presenting with frequent, recurrent corneal
erosions in the first decade but with a relatively mild clinical
appearance.  This  phenotype  is  not  that  of  the  classic
(posterior) stromal Fleck dystrophies, and while it clearly
exhibits  multiple  anterior  stromal  flecks,  the  corneal
localization of larger circular/oval opacities at the level of
Bowman  layer  and  anterior  stroma  suggests  an  anterior
membrane  type  dystrophy.  This  pedigree  is  assumed
dystrophic  predominantly  because  of  the  inheritance,
bilaterality, and exclusion of long-term and/or recent contact
lens wear.
We aimed to determine the causative genetic mechanism
for  this  disease  by  undertaking  mutational  analysis  of
candidate  corneal  genes  and  linkage  analysis  to  known
corneal genes and loci.
METHODS
Following  informed  consent,  20  members  of  the  three-
generation family (Figure 1) were recruited, and all members
were  characterized  clinically  with  visual  acuity,
autorefraction,  slit-lamp  biomicroscopic  examination,  and
Orbscan  II  slit-scanning  elevation  topography  (Bausch  &
Lomb Surgical, Rochester, NY). Selected individuals also
underwent  in  vivo  confocal  microscopy  (Confoscan  2;
Fortune Technologies, Greensboro, NC and/or Heidelberg
Retina  Tomograph  II,  Rostock  Corneal  Module  [RCM];
Heidelberg Engineering GmbH, Heidelberg, Germany). This
study adhered to the principles of the Declaration of Helsinki
and received institutional ethics approval (AKX0200002 and
NTX0612161).
Since the clinical manifestation of the disease is relatively
mild,  being  restricted  to  corneal  erosive episodes without
visual  impairment,  none  of  the  affected  individuals  have
undergone  corneal  biopsy  or  penetrating  keratoplasty.
Therefore, histological analysis was unavailable.
Biological samples (peripheral venous blood or saliva
specimen) were collected for DNA extraction, which was
obtained using the salt extraction method from blood [10] and
according  to  the  manufacturer’s  instructions  for  saliva
specimens (OrageneTM; DNAGenotek, Ottawa, ON, Canada).
Mutational analysis of all 17 coding exons of TGFBI was
undertaken using previously described primers and methods
[11,12].
Recurrent corneal erosions in a patient with epithelial
basement  membrane  dystrophy  have  been  described  as
occurring  concurrently  with  posterior  polymorphous
Figure  1.  Pedigree  of  the  reported
family. Individuals III:5, III:6, III:7, and
III:8 are younger than the average age of
onset of symptoms, therefore affectation
status can not be assigned.
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1701dystrophy (PPD) [13]. Localized bullous epithelial changes
are also described occurring in association with PPD [14].
Mutational analysis of nine coding exons of ZEB1 (zinc finger
E box-binding homeobox 1), formerly TCF8, (transcription
factor  8)  a  corneal  gene  implicated  in  PPD,  was  also
undertaken using previously described primers and methods.
For exon 1; primers were from Aldave et al. [15], for exons
2-9 primers were from Krafchak et al. [16]. Polymerase chain
reaction (PCR) amplification was undertaken using Roche
Faststart  polymerase  (F.  Hoffman-La  Roche  Ltd.,  Basel,
Switzerland). The amplification cycles were 95 °C for 5 min,
then 30 cycles of 95 °C for 30 s, annealing temperature (varied
by primer pair) for 1 min, 72 °C for 1min. A final extension
step of 72 °C for 10 min then completed the PCR reaction.
Product was visualised on a 1.5% agarose gel. For sequencing,
the products were purified with Roche HighPure PCR product
purification  kit  (F.  Hoffman-La  Roche  Ltd.),  and  then
sequenced  using  the  same  primer  pair.  Sequences  were
examined manually and with CLC DNA workbench (CLCbio,
Aarhus, Denmark) and aligned with genomic DNA reference:
NC_000010.10  and  mRNA  reference  sequence
NM_030751.4.
A  DNA  sample  of  the  proband  was  sent  to  Asper
Ophthalmics (Tartu, Estonia) and tested against the Corneal
Dystrophy chip, Version 2.0 (Asper Ophthalmics). A review
of  the  literature  identified  known  corneal  genes  and  loci
implicated  in  the  pathogenesis  of  corneal  disease,  and
bioinformatic databases were used to identify flanking and
intragenic  polymorphic  microsatellite  markers  for  each
known gene. For these candidate loci, polymorphic markers
were selected to cover the interval. If one marker failed to
adequately amplify or demonstrated low informativeness in
the  family,  a  further  marker  was  identified.  The  loci  and
markers used are shown in Table 1.
Primer pairs were synthesized and PCR amplification
undertaken using Roche Faststart polymerase (F. Hoffman-La
Roche Ltd.). The amplification cycles were as described for
TCF8/ZEB1 above, with annealing temperature varying for
each primer pair in order to optimise the amount of product.
Samples  were  then  run  on  ABI3700  Genotyper,  (Applied
Biosystems Inc., Foster City, CA), and ABI software was used
to  assign  the  peaks.  Haplotypes  were  constructed,  and
multipoint linkage analysis using GeneHunter v2.1 [17] was
undertaken  to  generate  LOD  plots  across  the  candidate
regions.
RESULTS
The  clinical  features  of  members  of  this  pedigree  are
summarized in Table 2.
Affected individuals typically presented in childhood at
an average age of six years with recurrent corneal erosions
(RCEs), occurring approximately every two to three months.
These RCEs became much less frequent in the third and fourth
decade,  indeed,  with increasing age, the recurrent epithelial 
erosions  became less frequent, and  the episodes appeared 
to  largely  “burn out”  by early to mid 20s. A few of the 
older   adults    reported   photophobia    and   foreign   body 
sensation  and  continued   to   use   topical   ocular  lubricants 
frequently  for ocular  comfort. Due  to their very young age, 
four  individuals in the  youngest generation could not yet 
be assigned affectation status.
Three  slit-lamp  biomicroscopic  corneal  features  were
common to the six affected individuals: (1) accumulation of
small, variable size (0.2–1.5 mm diameter), discrete, grayish-
TABLE 1. CANDIDATE CORNEAL GENES AND LOCI.
Gene or locus Chromosomal location Number of markers
COLVIIIA2 1p34.3-p32 3
TACSTD2 1p32–31 3
PIP5K3 2q33.3 10
KTCN3 locus 3p14-q13 6
GSN 9q34 3
KERA 12q22 3
KRT3 12q12-q13 3
Hughes Keratoconus [25,26] 15q22.33–24.2 8
VSX1 20p11-q11 3
MMP9 20q12 4
COLVIA1 21q22.3 3
For each candidate gene or locus of interest (column 1) the chromosomal location is given (column 2). Also for each locus the
number  of polymorphic microsatellite markers used for linkage analysis across each interval is stated in column 3. Abbreviations
in the table are: COLVIIIA2 = Collagen, Type VIII, Alpha-2, TACSTD2 = Tumor-Associated Calcium Signal Transducer 2,
PIP5K3  = Phosphatidylinositol-3-Phosphate 5-Kinase, Type III, KTCN3 = keratoconus 3, GSN = Gelsolin, KERA = Keratocan,
KRT3  = Keratin 3,  VSX1  = Visual System Homeobox Gene 1, MMP9 = Matrix Metalloproteinase 9, COLVIA1 = Collagen,
Type VI, Alpha-1.
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xwhite oval-round or annular opacities at the level of Bowman
layer and the superficial anterior stroma (typically less than
six lesions per cornea; Figure 2); (2) numerous, prominent
small gray flecks in the anterior 20%–25% of the stroma
extending from the central cornea to the limbus; and (3) five
of the six affected subjects also had prominent corneal nerves
(with reduced corneal sensation more prevalent in the older
members of the pedigree). The lesions identified appeared on
a background of a generally clear translucent cornea with no
involvement of the deeper stroma, Descemet membrane, or
the  endothelium,  and  there  was  an  absence  of
neovascularization.
Orbscan II slit-scanning elevation topography (Bausch &
Lomb Surgical) of affected individuals demonstrated normal
keratometric patterns and pachymetry. Subsequent in vivo
confocal  microscopy  confirmed  that  the  corneal  opacities
were restricted to the area of Bowman layer and anterior
stroma (Figure 3 and Figure 4), and there appeared to be no
abnormalities of the anterior keratocytes or stromal deposits
consistent with the clinical appearance of multiple diffuse
anterior stromal flecks.
Three  clinically  unaffected  individuals  demonstrated
faint stromal flecks of size consistent with keratocytes (I:1, II:
7,  III:7).  None  of  the  clinically  unaffected  individuals
demonstrated  the  Bowman  layer  circular/oval  opacities
observed in the affected subjects.
No pathogenic mutations were identified in any of the 17
coding exons and flanking intronic regions of TGFBI or in the
nine coding exons and flanking intronic regions of ZEB1.
Testing of an affected individual’s DNA against the Asper
Corneal Dystrophy microarray Version 2.0 (302 mutations in
12 genes: COL8A2 (Collagen, Type VIII, Alpha-2), TGFBI,
VSX1  (Visual  System  Homeobox  Gene  1),  CHST6
(Carbohydrate Sulfotransferase 6), KRT3 (Keratin 3), KRT12
(Keratin 12), GSN (Gelsolin), TACSTD2 (Tumor-Associated
Calcium Signal Transducer 2), CYP4V2, (Cytochrome P450,
Family 4, Subfamily V, Polypeptide 2) SOD1 (Superoxide
Dismutase 1;), ZEB1 and SLC4A11 (Solute Carrier Family 4
[Sodium Borate Cotransporter], Member 11) revealed a non-
pathogenic  heterozygous  sequence  change  in  CHST6  (c.
484C>G), resulting in p.R126G but no pathogenic mutations.
Figure 2. Slit lamp images of corneas of
affected  family  members.  Slit  lamp
images of cornea highlighting diffuse,
small, gray anterior stromal flecks (A-
F)  and  larger,  discrete  circular/oval/
annular  gray/white  opacities  (0.2–1.5
mm) at the level of Bowman's layer (C-
F,  small  arrowheads)  and  prominent
corneal nerves (D, fine arrow). A: Slit
lamp image of right cornea of individual
I:2, age 64 years, at 10× magnification,
demonstrating  diffuse  small  gray
anterior  stromal  flecks  and  annular
opacities.  B:  Slit  lamp  image  of  left
cornea of individual II:5, age 37 years,
at  10×  magnification  demonstrating
diffuse  small  gray  anterior  stromal
flecks and annular opacities. C and D:
Slit  lamp  images  of  right  cornea  of
individual  II:3,  at  10×  magnification
(C)  and  16×  magnification  (D).  The
annular opacities are clearly visualised
(small  arrowhead)  with  prominent
corneal nerves visible (fine arrow; E and
F) Slit lamp images of right and left
corneas respectively of individual III:2,
age  14  years,  at  10×  magnification
showing  the  annular  opacities
highlighted with arrowheads.
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1704Multipoint linkage analysis of nine genes and loci shown
in Table 1 was predominantly negative across the intervals.
Although the maximum LOD score achievable in this family
with the current information is 2.1, the LOD plots generated
by multipoint linkage analysis (Figure 5) suggest that all tested
candidate  loci  are  excluded  or  highly  unlikely  to  be
responsible.
DISCUSSION
This pedigree consisted of three generations with six affected
individuals  that  clearly  demonstrate  autosomal  dominant
inheritance. The clinical phenotype in this pedigree is of early
onset recurrent erosions associated with an unusual anterior
membrane/fleck dystrophy. Some features are similar to the
original description in 1966 of an eponymous entity, Grayson
Wilbrandt  dystrophy  (GWD)  [18].  GWD  varies  from  the
classic  fleck  description–  GWD  was  described  with
infrequent erosions, and a less severe effect on vision than
occurred  in  the  Bowman  layer  dystrophies.  The  original
clinical  description  of  GWD  is  of  gray-white  amorphous
opacities of various sizes over the central cornea, consisting
of mounds extending into the epithelium from a thickened
Bowman layer with a clear intervening stroma. Corneal nerves
were described as prominent.
Further  characterization  of  corneal  dystrophies,
particularly fleck dystrophy, can be achieved using in vivo
confocal microscopy (IVCM) with typical findings consisting
of  hyper-reflective  spots  within  pleomorphic  keratocyte
nuclei as previously described [5,6,19].
The  phenotypic  presentation  in  the  pedigree  here
particularly with frequent erosions is more in keeping with a
TGFBI  dystrophy.  Given  the  spectrum  of  phenotypic
variability demonstrated in the TGFBI-associated dystrophies
to date with the presence of photophobia and recurrent corneal
erosions in many of the family members, mutational analysis
of  TGFBI  was  believed  to  be  a  valid  first  approach.
Interestingly,  TGFBI  analysis  failed  to  demonstrate  any
pathogenic mutation.
Mutational analysis using the corneal dystrophy disease
microarray  (Asper  Ophthalmics)  tested  for  all  known
mutations  in  addition  to  single  nucleotide  polymorphisms
(SNPs) in 12 corneal genes, but none of the known mutations
were identified in the proband. As no TGFBI mutation was
identified in this pedigree and the phenotype is a “unique”
dystrophy,  genotyping,  haplotype  construction,  and
multipoint linkage to candidate loci and genes including the
Fleck  locus  on  2q35  (where  subsequently  PIP5K3  was
identified  as  the  causative  gene)  were  undertaken.  This
method is useful to determine if any candidate genes warrant
sequencing including PIP5K3, a very large gene of 41 exons
encompassing more than 89 kb.
PIP5K3 is a member of the phosphoinositide 3-kinase
family  and  regulates  the  sorting  and  traffic  of  peripheral
endosomes  that  contain  lysosomally  directed  fluid  phase
cargo  by  controlling  the  morphogenesis  and  function  of
multivesicular bodies.
Limitations of the methods used for gene or loci exclusion
include  the  Asper  Corneal  Dystrophy  microarray  only
excluding known mutations in known genes. As the genes not
Figure 3. In vivo confocal microscopy
(IVCM): Confoscan 2 images of I:2. A:
IVCM image of normal epithelium with
prominent  nuclei  visible.  B:  IVCM
image  at  the  level  of  Bowman
membrane  demonstrating  abnormal
diffuse  hyper-reflectivity.  C:  IVCM
image at the level of the posterior stroma
demonstrating  a  normal  keratocyte
appearance with no evidence of hyper-
reflective  structures  (flecks)  either
within  the  keratocytes,  or  in  the
extracellular regions. D: IVCM image at
the  level  of  the  endothelium,
demonstrating  normal  healthy
endothelium.
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1705excluded  by  microsatellite  analysis  and  linkage  (e.g.,
CHST6,  KRT12,  SLC4A11,  and  SOD1)  were  not  fully
sequenced, it is feasible that a unique mutation may reside on
one of the candidate genes. Similarly, sequencing of TGFBI
did include all coding exons and flanking intronic regions but,
theoretically, would not detect copy number variants within
the TGFBI open reading frame (ORF).
This dystrophy shows some similarities to two recently
described  autosomal  dominant  dystrophies  with  recurrent
corneal  erosions,  Dystrophia  Helsinglandica  [20]  and  the
Dystrophia Smolandiensis variant [21]. However, Dystrophia
Helsinglandica  gradually  manifests  with  subepithelial
fibrosis, and the Dystrophia Smolandiensis variant results in
keloid-like  corneal  nodules  with  penetrating  keratoplasty
Figure 4. In vivo confocal microscopy
(IVCM): Heidelberg Retina Tomograph
II, Rostock Corneal Module images of
individual II:3. A: IVCM image at the
level  of  the  basal  epithelium,
demonstrating two irregular amorphous
regions  of  Bowman  layer  protruding
forwards into the epithelium, visible in
the upper and lower aspect of the image.
B: IVCM image at the level of Bowman
layer, demonstrating a diffuse, irregular
hyper-reflectivity. Sub-basal nerves are
not visible. C: IVCM image at the level
of  the  anterior  stroma,  demonstrating
patchy areas of hyper-reflectivity within
the  stroma  with  hyper-reflectivity  of
keratocytes. D: IVCM image at the level
of  the  midstroma,  demonstrating
unusual, tortuous stromal nerves with
normal keratocytes. E: IVCM image at
the  level  of  the  posterior  stroma
demonstrating normal architecture and
normal keratocytes. F: IVCM image at
the  level  of  the  endothelium,
demonstrating  normal  healthy
endothelium.
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1706often  being  required.  There  are  also  some  similarities  to
subepithelial mucinous corneal dystrophy (SMCD), although
more significant vision loss resulted in the one SMCD family
described [22]. Franceschetti [23] described a pedigree with
RCE in 1928. However, as this original description is limited
to one boy, it is difficult to determine similarities. Using the
IC3D (International Committee for Classification of Corneal
Dystrophies)  classification  [1],  this  anterior  membrane
dystrophy falls in the descriptive category 4: “This category
is reserved for a suspected new, or previously documented
corneal  dystrophy,  although  the  evidence  for  it,  being  a
distinct entity, is not yet convincing” [1].
By resolving the affectation status of the four children in
the  youngest  generation  (III-5,III-6,  III-7,  and  III-8),  the
statistical power increases so as to achieve a potential LOD
score  of  around  3.3,  suitable  for  providing  positive  gene
localization in a genome-wide linkage study. This phenotype
has an age-dependent penetrance, so until all of these younger
children reach 10 years of age, one cannot confidently label
them as unaffected. Non-penetrance may also be an issue as
has been described occurring in fleck dystrophy associated
with PIP5K3 mutations [8] and in some of the  TGFBI –
associated corneal dystrophies [24]. This issue may reduce
somewhat  the  power  of  linkage  based  approaches  in  this
family.
Thus,  to  genetically  characterize  this  family  further,
ongoing clinical examination and observation of the younger
and clinically unaffected members of the pedigree must be
undertaken.  Once  affectation  status  can  be  more  tightly
assigned, it may be possible to obtain a higher potential LOD
score, which will permit a tighter search of the genome. This
could be rapidly achievable using SNP microarrays such as
the Affymetric Gene chip systems (Affymetrix, Santa Clara,
CA). The clinical findings, analysis of linkage, and mutational
analysis suggest this family may provide a clue to a novel
genetic  mechanism  and/or  genes  implicated  in  the
pathogenesis  of  the  dominantly  inherited  anterior  corneal
dystrophies.
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